MENU
TBXU
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

TBXU stock forecast, quote, news & analysis

The investment seeks daily investment results, before fees and expenses, of 200% of the daily performance of the NYSE Biotechnology Index... Show more

Category: #Trading
Interact to see
Advertisement
A.I.Advisor
published price charts
TBXU
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for TBXU with price predictions
Oct 16, 2026

TBXU's RSI Oscillator recovers from oversold territory

The RSI Oscillator for TBXU moved out of oversold territory on October 09, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 2 similar instances when the indicator left oversold territory. In 2 of the 2 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on TBXU as a result. In 11 of 13 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.

The Moving Average Convergence Divergence (MACD) for TBXU just turned positive on October 15, 2026. Looking at past instances where TBXU's MACD turned positive, the stock continued to rise in 7 of 9 cases over the following month. The odds of a continued upward trend are 78%.

Following a +7.21% 3-day Advance, the price is estimated to grow further. Considering data from situations where TBXU advanced for three days, in 39 of 44 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.

TBXU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

TBXU moved below its 50-day moving average on October 01, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for TBXU crossed bearishly below the 50-day moving average on October 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 2 of 2 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TBXU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

The Aroon Indicator for TBXU entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN).

Industry description

The investment seeks daily investment results, before fees and expenses, of 200% of the daily performance of the NYSE Biotechnology Index. The fund, under normal circumstances, invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments, such as swap agreements, securities of the index, and exchange-traded funds ("ETFs") that track the index, that, in combination, provide 2X daily leveraged exposure to the index, consistent with the fund's investment objective. The components of the index and the percentages represented by various sectors in the index may change over time. The fund is non-diversified.

Market Cap

The average market capitalization across the Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) ETF is 137.36B. The market cap for tickers in the group ranges from 51.65B to 229.74B. AMGN holds the highest valuation in this group at 229.74B. The lowest valued company is ARGX at 51.65B.

High and low price notable news

The average weekly price growth across all stocks in the Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) ETF was 4%. For the same ETF, the average monthly price growth was 0%, and the average quarterly price growth was 26%. REGN experienced the highest price growth at 3%, while VRTX experienced the biggest fall at -1%.

Volume

The average weekly volume growth across all stocks in the Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) ETF was 53%. For the same stocks of the ETF, the average monthly volume growth was 41% and the average quarterly volume growth was -40%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 74
P/E Growth Rating: 52
Price Growth Rating: 34
SMR Rating: 50
Profit Risk Rating: 28
Seasonality Score: 41 (-100 ... +100)
View a ticker or compare two or three
TBXU
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Trading

Category
Trading--Leveraged Equity
Address
Direxion Shares ETF Trust33 Whitehall Street,10th FloorNew York
Phone
866-476-7523
Web
http://www.direxioninvestments.com/
TBXU's RSI Oscillator recovers from oversold territory